HS.B1 Late Application Closes 01/02/18
×

HS.Build Applications Are Open
APPLY NOW

HS.Community

The Latest Health Tech and HS. News

5 Things I Learned From Healthtech Podcasting In 2019 🎙

1170 min read

In October 2018, we started The HS. Health-Tech Podcast. The goal was to connect everyone in healthtech from around the world and to spread the best insights from our own learning and from successful entrepreneurs. Through 2019 it grew rapidly. We saw almost 20% week-on-week growth, and listeners went from solely in the UK to 84 different countries. Here are 5 things I've learned from hosting:

Read More

HS. Health-Tech Talks Sponsored By Hempsons In 2020

214 min read

We're excited to announce that Hempsons are now sponsoring the HS. Health-Tech Talks series throughout 2020. The HS. Health-Tech Talks are a series of ‘unplugged’ health-tech talks, real-life stories, Q&As and networking in a fun and interactive format to help entrepreneurs, future founders and anyone looking to learn about the health-tech sector.

Click here to register for the January event!

Read More

HS.Podcast - Episode 37: The Story of Jud Brewer, Digital Therapeutics and Mindful Tech 📱

264 min read

James is joined by Dr. Jud Brewer who holds the position of 4th most-watched TED talk ever, with 12 million views. Jud is the founder of MindSciences Inc developing digital therapeutics in the area of addiction, he is Director of Research and Innovation at the Mindfulness Center and associate professor in psychiatry at the School of Medicine at Brown University and research affiliate at MIT.

Read More

Could The NHS Really Sell Its Data For $12 Billion?

110 min read

HS. cofounder Dr. James Somauroo's latest for Forbes: A new report by consulting firm EY suggests that if the U.K. National Health Service (NHS) datasets were put to use, their value could be up to £9.6 billion ($12 billion) per year.

Read More

HS.Podcast - Episode 35: The Story of Flagship Pioneering and The Future of Medicines 🧪

296 min read

James is joined by Dr. Paul-Peter Tak, Venture Partner at Flagship Pioneering and CEO of Kintai Therapeutics. Over a more than 25-year career in the life sciences, Paul-Peter has created and led multiple companies. From 2011 until 2017, Paul-Peter founded and served as senior vice president and head of the immuno-inflammation therapy area unit at GSK.

Read More

Feebris Raise £1.1M

61 min read

HS. portfolio company Feebris has announced a successful seed investment raise of £1.1 million. The funding enables the company to continue its innovation in AI for precision diagnosis of respiratory conditions in elderly patients in the UK and young children in India.

Read More

HS. Healthtech Investor Summit

267 min read

In association with the UK Business Angels Association and British Venture Capital Association, HS. presented a fantastic investor only Investor Summit - a half-day educational event focusing on industry trends, investment opportunities and look ahead at what emerging technologies will shape the sector.

Read More